J F Tomera1, A F Kaul. Show Affiliations » 1. Medical Outcomes Management, Inc., Foxborough, MA 02035, USA.
Abstract
Entities: Disease
Mesh： See more » Arterial Occlusive Diseases/drug therapyArterial Occlusive Diseases/prevention & controlHumansInfusions, Intra-ArterialPeripheral Vascular Diseases/drug therapyPeripheral Vascular Diseases/prevention & controlPlasminogen Activators/economicsPlasminogen Activators/therapeutic useStreptokinase/economicsStreptokinase/therapeutic useThrombolytic Therapy/economicsThrombophlebitis/drug therapyThrombophlebitis/prevention & controlUrokinase-Type Plasminogen Activator/economicsUrokinase-Type Plasminogen Activator/therapeutic use
Substances： See more » StreptokinasePlasminogen ActivatorsUrokinase-Type Plasminogen Activator
Year: 1997 PMID： 9290897 DOI： 10.1093/ajhp/54.17.1988
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN： 1079-2082 Impact factor: 2.637